For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...
The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.
Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its ...
GeneDx CEO Katherine Stueland likes the potential of newborn testing, but she says her Stamford, Connecticut, company is ...
Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
Justin Baldoni’s high-profile litigator Bryan Freedman has been on the warpath to defend his client in the evolving drama over It Ends With Us.Weeks after filing a $250 million libel suit ...
in lung function improvement with an acceptable safety profile in patients with cystic fibrosis. Researchers conducted two randomized, double-blind phase 3 trials (SKYLINE VX20-121-102 and VX20 ...
More than 162,000 people worldwide are estimated to be living with CF. Credit: Orawan Pattarawimonchai/Shutterstock. Glox Therapeutics is set to receive a share of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback